Regulated intramembrane proteolysis is a method for transducing signals between cellular compartments. When protein folding is compromised in the periplasm of E. coli, the C termini of outer-membrane proteins (OMPs) bind to the PDZ domains of the trimeric DegS protease and activate cleavage of RseA, a transmembrane transcriptional regulator. We show here that DegS is an allosteric enzyme. OMP binding shifts the equilibrium from a nonfunctional state, in which the active sites are unreactive, to the functional proteolytic conformation. Crystallographic, biochemical, and mutagenic experiments show that the unliganded PDZ domains are inhibitory and suggest that OMP binding per se is sufficient to stabilize the relaxed conformation and activate DegS. OMP-induced activation and RseA binding are both positively cooperative, allowing switch-like behavior of the OMP-DegS-RseA system. Residues involved in the DegS allosteric switch are conserved in the DegP/HtrA and HtrA2/Omi families, suggesting that many PDZ proteases use a common mechanism of allosteric activation.
INTRODUCTION
Regulated intramembrane proteolysis (RIP) mediates signal transduction between different membrane-bounded cellular compartments in all domains of life (Brown et al., 2000) . RIP systems require two proteases. The first protease senses an initial signal and responds by cleaving a transmembrane protein on one side of a membrane (site-1 cleavage). In response, the second protease cleaves the same regulatory protein on the other side of the membrane (site-2 cleavage), allowing signal propagation. Although RIP systems are ubiquitous, the detailed mechanisms by which regulated intramembrane proteolysis is modulated remain largely undetermined.
In Escherichia coli, envelope or periplasmic stress initiates a RIP cascade in which the protease DegS and transmembrane regulator RseA play key roles (for review, see Raivio and Silhavy, 2001; Alba and Gross, 2004; Ehrmann and Clausen, 2004) . When protein folding and assembly in the periplasm are compromised or outer-membrane proteins (OMPs) are overexpressed, DegS cleaves the periplasmic domain of RseA, activating site-2 cleavage by protease RseP (Mecsas et al., 1993; Ades et al., 1999; Alba et al., 2001 Alba et al., , 2002 Kanehara et al., 2002; Akiyama et al., 2004) . The cytoplasmic N-terminal domain of RseA normally binds and inhibits the s E transcription factor (De Las Penas et al., 1997; Missiakas et al., 1997; Campbell et al., 2003) . However, site-2 cleavage releases N-RseAs E from the membrane, allowing N-RseA to be degraded by cytoplasmic proteases (Flynn et al., 2004; Chaba et al., 2007) . This final degradation step frees s E , allowing it to bind RNA polymerase and enhance transcription of genes for periplasmic chaperones, proteases, and biosynthetic enzymes (Rhodius et al., 2006) . How does DegS-a trimer of identical subunits, each with a membrane anchor, a trypsin-like protease domain, and a PDZ domain-sense the initiating signal for envelope stress? Peptides with C-terminal YxF sequences (where ''x'' can be many residues) bind the PDZ domain of DegS, activate DegS cleavage of the V148-S149 peptide bond of RseA in vitro, and induce the envelope-stress response in vivo (Walsh et al., 2003) . YxF is the C-terminal sequence of many OMPs but is sequestered in properly assembled OMPs, suggesting that DegS senses envelope stress by binding misfolded or unassembled OMPs. There are competing activation models. Because a DegS 6PDZ variant showed some activity in vivo, it was proposed that peptide binding reverses an inhibitory activity of the PDZ domain (Walsh et al., 2003) . Indeed, recent work shows that DegS 6PDZ and intact DegS cleave RseA to comparable extents in an end-point assay (Cezairliyan and Sauer, 2007) . Inferences from crystal structures suggested a different model (Wilken et al., 2004) , namely that the PDZ domain serves as a scaffold, presenting a bound OMP peptide in a manner that allows its penultimate side chain to contact the DegS protease domain and propagate conformational changes to the active site. These models make distinct predictions and have different biological implications. For example, if the penultimate peptide residue is critical for proper activation, then only a subset of unassembled OMPs or other periplasmic proteins will initiate the envelope-stress response. Moreover, peptides that bind but do not activate would play inhibitory roles. By contrast, if any peptide that binds to the PDZ domain also activates DegS, then integration of a wide variety of input signals would be possible.
Many proteases contain PDZ domains Kim and Kim, 2005) . For example, DegS shares strong sequence and structural homology with human HtrA2/Omi, a mitochondrial PDZ protease that is released into the cytoplasm during apoptosis and contributes to caspase-independent cell death (Li et al., 2002; Salelens et al., 2004) . Moreover, the E. coli site-2 RseP protease, as well as the periplasmic proteases DegP, DegQ, and Tsp, contain one or two PDZ domains. Thus, understanding how PDZ domains regulate protease activity is a problem of broad significance. The OMP-DegS-RseA system could serve as an important paradigm. Structures of unliganded DegS and the peptide-bound enzyme are known (Wilken et al., 2004; Zeth, 2004) , making it the best characterized PDZ protease from a structural perspective. However, published assays for DegS activity are not easily quantified, employ similar quantities of enzyme and substrate, and require long incubations (Walsh et al., 2003) . Thus, the mechanism of OMP activation of DegS cleavage of RseA has yet to be rigorously investigated.
Using improved quantitative assays, we show here that DegS behaves as a classical allosteric enzyme. The binding of OMP peptides shifts the equilibrium from an inactive state, in which the active site is unreactive, to a functional proteolytic conformation. Allostery gives rise to positive cooperativity in the activation of DegS by OMP peptides. A different mechanism, substrate-substrate interactions, mediates positive cooperativity in RseA binding to DegS. We present evidence that the unliganded PDZ domain of DegS is inhibitory. DegS 6PDZ and DegS cleave RseA with similar steady-state kinetics, and the crystal structure of DegS 6PDZ resembles the protease domain of active peptide-bound DegS. Detailed studies of mutant variants of DegS, DegS
6PDZ
, and OMP peptides are also inconsistent with several predictions of the proposed scaffold model for DegS activation. Rather, we suggest that activation occurs when any YxF or related peptide sequence binds preferentially to the relaxed or active conformation of DegS. We find that a residue conserved in DegS, DegP, DegQ, and HtrA2 plays a critical role in the allosteric switch between the inactive and active states of the protease, suggesting that many PDZ proteases use a common allosteric mechanism of peptide activation.
RESULTS

A Quantitative Assay for DegS Cleavage of RseA
For this work, we used a soluble DegS variant with an N-terminal His 6 tag and no membrane anchor. Previous studies showed that this variant (called DegS for simplicity) cleaved the periplasmic domain of RseA (residues 121-216; RseA peri ) at a single site when OMP peptide was present (Walsh et al., 2003) . We found that the reaction time could be reduced from hours to minutes by optimizing conditions and that cleavage of 35 S-labeled RseA peri could be quantified by an acid-precipitation assay (see Experimental Procedures). These assay conditions did not alter the reaction products or dependence on OMP peptide ( Figure 1A ) and gave linear initial rates that were proportional to DegS concentration ( Figures  1B and 1C ). The maximum velocity or turnover number for DegS cleavage of RseA (1.1 ± 0.2 s À1 DegS 3 À1 ) was fast enough to account for the fact that intracellular RseA levels drop within minutes of a stress signal (Ades et al., 1999) . The apparent K M (750 ± 120 mM) was about 10-fold higher than estimates for RseA levels in the periplasm ($80 mM) (Grigorova et al., 2006; Cezairliyan and Sauer, 2007 Figure 1D ). If DegS DPDZ is already in an active conformation, however, then allostery cannot be responsible for the cooperativity of substrate cleavage. Hence, interactions between enzyme-bound RseA peri substrates probably explain the observed positive cooperativity.
We mutated the V148-S149 sequence flanking the DegS cleavage site in RseA peri to A148-A149 (AARseA peri ) and found that this mutant was cleaved far more slowly by DegS ( Figure 1A A Self-Activating Substrate for DegS The RseA peri cleavage rate was not saturated at the highest soluble substrate concentration ($1.5 mM; Figure 1C ). To obtain a tighter-binding substrate, we fused the C-terminal tripeptide of E. coli OmpC (YQF) to the C terminus of RseA peri , reasoning that this fusion substrate would bind more tightly by tethering itself to the PDZ domain of DegS and also be self activating. As anticipated, the K M was substantially lower (33 ± 5 mM) and saturation of the DegS cleavage rate was readily achieved in the absence of added OMP peptide ( Figure 1F) . Surprisingly, however, the Michaelis-Menten plot was not sigmoid and positively cooperative but was hyperbolic. This result suggests that the fusion substrate interacts with DegS in a manner that precludes favorable substrate-substrate interactions. Binding of the C termini of fusion substrates to the PDZ domains might prevent favorable interactions. Alternatively, binding of one fusion substrate might block binding of other fusion substrates. DegS 6PDZ cleaved low concentrations of the fusion substrate at the same rate as it cleaved RseA peri , demonstrating that enhanced DegS cleavage of the fusion substrate is PDZ dependent (data not shown).
Allosteric Activation by OMP Peptide
Using fixed amounts of DegS and RseA peri , we determined the cleavage rate as a function of YYF-OMP-peptide concentration. DegS displayed a very low basal rate of cleavage in the absence of OMP peptide (2.9 ± 0.5 M À1 s À1 ), which increased about 230-fold at high YYFpeptide concentrations ( Figure 2A ). Based upon replicate measurements, half-maximal activation of DegS cleavage occurred at a YYF-peptide concentration of 3.9 ± 0.8 mM and the Hill constant was 1.9 ± 0.2, a signature of positive cooperativity. In the crystal structure of the peptidebound DegS trimer (1soz), the OMP peptides are 50-60 Å apart (Wilken et al., 2004 ) (see Figure 3A ), ruling out favorable peptide-peptide interactions as the cooperativity source. Hence, YYF-peptide binding appears to favor an allosteric change from a tense or inactive DegS conformation to a relaxed or active conformation that binds peptide more tightly and is proteolytically active (Monod et al., 1963 (Monod et al., , 1965 . DegS bound a fluorescein-modified YYF peptide half maximally at a concentration of 4.6 ± 0.2 mM (subunit equivalents; Figure 2B ), in good agreement with the peptide concentration required for half-maximal DegS activation ( Figure 2A ). However, the isolated PDZ domain of DegS bound the fluorescein-YYF peptide more tightly (K D = 0.64 ± 0.07 mM), a value within error of the binding constant for an unmodified YYF peptide measured by isothermal titration calorimetry (0.63 ± 0.1 mM; Walsh et al., 2003) . Together, these results suggest that tertiary and quaternary interactions hold the PDZ domains in unliganded DegS in a nonoptimal conformation for OMP-peptide binding. This behavior is a hallmark of the concerted and sequential models of allostery (Monod et al., 1965; Koshland et al., 1966) .
Role of the Penultimate Residue in OMP Peptides
The peptide-scaffold model proposes that the penultimate side chain of the PDZ-bound OMP peptide, by making a contact with the L3 loop, plays a critical role in driving a conformational change in the DegS protease domain (Wilken et al., 2004) . Although many penultimate OMP-peptide residues were functional in their study, Wilken et al. (2004) reported that small or negatively charged side chains (e.g., YAF, YSF, and YDF) failed to activate DegS. By contrast, we found that the YAF, YSF, YDF, YQF, YRF, and YYF peptides all activated DegS cleavage of RseA peri to roughly comparable extents, although with varied apparent affinities (Table 1 and Figures  2A and 2C ). As seen previously for the YYF peptide, DegS binding to fluorescein-modified YAF and YQF peptides correlated reasonably with the peptide concentration required for half-maximal activation, whereas the isolated PDZ domain of DegS bound these peptides more tightly (Table 1) . We conclude that the chemical identity of the penultimate residue of the OMP peptide plays a role in establishing affinity for DegS but is not a principal determinant of the activation mechanism. Hence, any protein with an accessible YxF sequence at its C terminus could contribute to DegS activation.
Active-Site Reactivity and OMP-Peptide Binding
Crystal structures suggest that the geometry of the oxyanion hole and the DegS catalytic triad (H96, D126, and S201) should not support protease activity in DegS without bound OMP peptide (Wilken et al., 2004; Zeth, 2004) . To test this hypothesis, we treated DegS and DegS 6PDZ with diisopropylfluorophosphate (DFP), a protease inhibitor that covalently modifies active-site serines. In the presence of OMP peptide, DFP inhibited DegS completely within 10 min ( Figure 2D ). DegS 6PDZ was inhibited with the same kinetics in the absence of peptide. By contrast, no DFP inactivation of DegS was observed over 10 min without OMP peptide ( Figure 2D) . Thus, the active-site reactivity of intact DegS changes dramatically upon OMP-peptide binding to the PDZ domain. This result supports an allosteric model in which the unliganded PDZ domains stabilize a nonfunctional DegS conformation.
Without YYF peptide, no inhibition of DegS by DFP was observed in the presence of 250 mM RseA peri (data not shown). This finding suggests that RseA does not bind preferentially to the relaxed state or that binding is too weak to affect the tense-relaxed allosteric equilibrium at this substrate concentration.
Crystal Structures of DegS
6PDZ
We crystallized selenomethionine-substituted DegS 6PDZ , collected X-ray diffraction data to 2.5 Å resolution, determined SAD phases, and refined the structure (Table 2 ). protease and PDZ domains, the active sites, and an YQF-OMP peptide. This symmetric trimer was generated using three copies of the A chain of 1soz (Wilken et al., 2004) . The actual 1soz trimer is asymmetric. (B) Superposition of four independent structures of the DegS DPDZ trimer in cartoon representation. The LA loops (residues 65-75; pink), the LD loops (residues 160-167; orange), the L3 loops (residues 176-189; red) and the L2 loops (residues 219-232) are colored differently from the main body of the structure (blue-purple This crystal form (2QF0) contained three trimers per asymmetric unit. Subsequently, we obtained a second crystal form (2QF3) with one trimer per asymmetric unit and solved this structure by molecular replacement (2.04 Å ; Table 2 ). Together, these structures provide independent views of four DegS 6PDZ trimers and 12 DegS 6PDZ subunits in distinct crystallographic environments.
The different DegS 6PDZ trimers had similar structures (<0.5 Å rmsd for main-chain atoms), with the biggest differences occurring in the LA, L2, and L3 loops, which were completely or partially disordered in many subunits ( Figure 3B ). In most DegS 6PDZ subunits, the active-site residues and the oxyanion hole resembled the corresponding portion of peptide-bound DegS rather than peptide-free DegS ( Figure 3C ), although the H96 side chain assumed different rotamer conformations in one subunit of the 2QF0 structure. Nevertheless, these structural results are in general accord with the functional results discussed above and imply that the PDZ domains of DegS normally hold the protease domains in an inactive conformation.
Parts of the DegS L3 loop (residues 176-189) contact the PDZ domain in peptide-free DegS but assume a 
, where I j (h) is the j th reflection of index h and <I(h)> is the average intensity of all observations of I(h). R work = S h jF obs (h) -F calc (h)j j / S h jF obs (h)j, calculated over the 95% of the data in the working set. R free equivalent to R work except calculated over the 5% of the data assigned to the test set. Numbers in parentheses represent values for the highest resolution bin. different conformation in the peptide-bound structure (Wilken et al., 2004; Zeth, 2004) . In our structures, significant parts of the L3 loop were disordered in many subunits, but the L3 loops that were ordered assumed a different conformation than observed in the peptide-bound DegS structure ( Figure 3D) . Hence, the precise conformation of the entire L3 loop does not appear to be an important determinant of ''active'' DegS structures. Wilken et al. (2004) proposed that the peptide-bound L3-loop conformation supported additional structural changes, including formation of a hydrogen bond between the side chains of E227 in the L2 loop and Y162 in the LD loop, which were responsible for restructuring the active site. However, the E227 side chain hydrogen bonded to the hydroxyl of Y162 in only one of the 12 DegS 6PDZ subunits and was completely missing from the electron-density map in the majority of subunits. Although these facts do not rule out an important role for E227, they were surprising in light of the high activity observed for DegS
.
Mutations at Y162, P183, and E227
In support of their activation model, Wilken et al. (2004) reported that the Y162A and E227A mutants of DegS were inactive. They also found that the L3-loop mutation P183A, which affects a contact with the PDZ domain, was inactive. Because our crystallographic results raised questions about the importance of an E227-Y162 interaction, we remade this set of three mutants as well as Y162F and tested degradation of RseA peri and RseA peri -YQF. In our assays, Y162A DegS had extremely low activity but the P183A and E227A DegS mutants were about as active or more active than the wild-type enzyme, respectively (Figures 4A and 4B and Table 3 ). Moreover, we found that the E227A and P183A mutants were also fully active under the assay conditions used by Wilken et al. (2004) (data not shown). Some DegS orthologs have phenylalanine at the position corresponding to Y162 in DegS. The Y162F mutant had about 40% of wild-type activity (Figures 4A and 4B and Table 2 ), suggesting that the hydroxyl group of Y162 plays some role in supporting the active conformation of DegS. E227 and P183 are poorly conserved in DegS orthologs. Thus, the activation model proposed by Wilken et al. (2004) could not apply generally to the broader DegS family and also fails to explain the phenotypes of mutants in E. coli DegS.
Allosteric Determinants of PDZ Inhibition
In the Monod-Wyman-Changeux (MWC) model of allostery, specific structural interactions preferentially stabilize the tense conformation relative to the relaxed conformation (Monod et al., 1965) . If the side chains mediating these interactions do not have additional roles, then mutating them should shift the equilibrium toward the relaxed state, increasing activity and reducing positive cooperativity. In unliganded DegS, contacts between the PDZ domain and the protease domain probably stabilize the tense/inactive enzyme conformation. In particular, three salt bridges (D122-R256, R178-E317/D320, and K243-E324) are formed between these domains in unliganded DegS ( Figure 3E ) (Wilken et al., 2004; Zeth, 2004) . Thus, in the absence of additional roles, the allosteric model predicts that mutation of these interface residues will increase basal DegS protease activity and reduce cooperativity. By contrast, the peptide-scaffold model predicts that disrupting contacts between the PDZ domain and the protease domain would reduce OMP-stimulated DegS activity (Wilken et al., 2004) .
To test these models, we mutated D122, R178, K243, R256, E317, D320, and E324, and also inserted an SSIGSS sequence between R253 and V254 increasing the length of the linker between the protease domain and the PDZ domain (designated DegS ext ). The P183A mutation described above also affects an interface contact between the PDZ and protease domains ( Figure 3E ). Most interface mutations (9/11) increased basal cleavage of RseA peri in the absence of OMP peptide (Table 3 and Figure 4C , upper panel). The K243D, R256A, R256D, and D320A substitutions and the SSIGSS insertion caused the most dramatic effects, increasing the basal rate of RseA peri cleavage 40-fold or more. In the cases studied, most mutations that increased basal protease activity also reduced the cooperativity of YYF activation of the cleavage reaction (Hill constants 1.1-1.4) and reduced the peptide concentration need for half-maximal activation (Table 3) . Moreover, the majority of interface mutants had OMP-stimulated activities equal to or greater than wild-type DegS (Table 3 and Figure 4C , lower panel). Thus, these results support an allosteric model in which contacts between the unliganded PDZ domain and the protease domain constrain DegS to an inactive conformation.
The D122-R256 salt bridge is present in both peptidefree and peptide-bound DegS (Wilken et al., 2004; Zeth, 2004) . Thus, it may seem surprising that the R256D and R256A mutations shift the allosteric equilibrium in favor of the relaxed/active DegS conformation. However, the strength of a salt bridge is determined not only by the interacting side chains but also by net electrostatic interactions with solvent and the rest of the structure (see Sheinerman et al., 2000 and references therein) . Hence, it is likely that the D122-R256 salt bridge is stronger in the peptide-free than in the peptide-bound conformation of DegS.
Two of the interface mutations, D122A and R178A, caused substantial reductions in the activities of DegS and DegS 6PDZ (Table 3) . These results suggest that D122 and R178, which are 99% conserved in DegS orthologs, play additional roles in DegS activity that are Maximum YYF-stimulated activities and basal activities were determined under k cat /K M conditions using at least three different DegS and three different RseA peri concentrations. K act and Hill constants for OMP-peptide activation were determined from two or more independent experiments like the one shown in Figure 2A with a fixed RseA peri concentration (200 mM). The steady-state parameters for cleavage of the RseA-YQF substrate are mean values of two or more independent experiments like the one shown in Figure 1F . n.a., no detectable activity; n.d., not determined. Estimated errors were calculated as described in the Table 1 legend. (y) The OMPpeptide concentration was too close to the enzyme concentration to determine reliable ''free'' peptide and thus a Hill constant. independent of the PDZ domain. For the R178 variants, activity ranged from 1%-11% depending on the DegS background and substrate. For the D122A mutants, activity was 4%-27% of wild-type. Partial activity of the D122A DegS mutant was also reported previously (Wilken et al., 2004) . As well as serving an interface role, D122 participates in a hydrogen-bonding network that includes the main-chain atoms of D126, a nearby active-site residue. These contacts may be necessary for the active conformation of the catalytic triad, explaining the reduced activity of the D122A mutant both in DegS and in DegS 6PDZ backgrounds. R178 is part of the L3 loop. The R178 side chain forms ion pairs with PDZ residues E317 and D320 in peptidefree DegS (Figure 3E ), but moves $19 Å and makes hydrogen bonds to the backbone of the LD loop in a neighboring subunit and to the Q191 side chain in the same subunit in DegS 6PDZ ( Figure 3F ). The Q191 side chain hydrogen bonds to the T167 side chain in the adjacent LD loop. Additional hydrogen bonds form a network that connects these interactions to the oxyanion hole ( Figure 3F ). Thus, it is plausible that repositioning of the R178 side chain is the key event in the allosteric switch from the inactive to the active conformation.
R178A Crystal Structure
Although contacts made by the R178 side chain in peptide-bound DegS could stabilize the relaxed/active conformation of DegS, it is also possible that the R178A mutant has low activity because it fails to trimerize or assumes an aberrant structure. To address these possibilities, we crystallized R178A DegS 6PDZ and solved its structure (2QGR; 2.7 Å resolution). There was only one DegS 6PDZ-R178A subunit in the asymmetric unit, but rhombohedral symmetry in the crystal generated a trimer with the same quaternary structure observed in the wild-type enzyme. Most parts of the mutant structure were also similar to wild-type (rmsd 0.66 Å for 625 common main-chain atoms). However, electron-density for residues 161-165 in the LD loop and residues 196-201 (including the active site S201 and oxyanion hole) was poor, and we could not model both regions without introducing steric clashes or unacceptable geometry. These regions probably assume multiple conformations, accounting for the low activity of the R178A mutant. Thus, the wild-type R178 side chain appears to play a role both in maintaining the inactive/ tense state of peptide-free DegS and in stabilizing the active/relaxed conformation of peptide-bound DegS or DegS 6PDZ .
DISCUSSION
The PDZ domains of the intact DegS trimer function as inhibitory modules. This model was originally suggested on the basis of genetic studies using the DegS 6PDZ variant (Walsh et al., 2003) . Here, we find that the protease activity of this variant is essentially the same as intact DegS activated by saturating OMP peptides. Thus, OMP-peptide binding to the PDZ domains activates DegS by relieving inhibition. We find no evidence for the competing ''scaffold'' model of activation, in which the PDZ domains function to present OMP peptides in a fixed orientation to the DegS protease domain, with the penultimate peptide side chain playing a key role in activation (Wilken et al., 2004) . For example, we find that YxF peptides with chemically and sterically disparate side chains at the penultimate position (alanine, serine, aspartic acid, glutamine, arginine, and tyrosine) all activate DegS to roughly the same extent. We also found that DegS can also be activated by peptides with other amino acids at the C-terminal and antepenultimate positions (unpublished data). Thus, we suspect that almost any C-terminal sequence that binds to the PDZ domain will activate DegS. From a biological perspective, this means that DegS should be able to sense and respond to the presence of numerous unassembled or misfolded proteins in the periplasm, although proteins with the highest affinities and abundance will be the most effective response activators.
Importantly, we find that DegS functions as an allosteric enzyme. In the tense or inactive conformation, structural studies show that the active-site triad (H96, D126, amd S201) and oxyanion hole do not have the proper geometry for catalysis (Wilken et al., 2004; Zeth, 2004) . For example, in the peptide-free 1te0 structure, the side chains of H96 and S201 are too far apart (4.4 Å ) to form a hydrogen bond, which is necessary to reduce the pK a and thus to increase the reactivity of the active-site serine. In the relaxed 1soz structure and our DegS 6PDZ structures, by contrast, a hydrogen bond between these side chains could be formed (average distance 3.46 ± 0.32 Å ; n = 14). Both peptide-bound DegS and DegS 6PDZ are inactivated by DFP, and preliminary crystallographic experiments show that Ser201 is the site of modification (unpublished data). However, peptide-free DegS does not react with DFP, even though its active-site residues are completely accessible in crystal structures (Wilken et al., 2004; Zeth, 2004) . These structural and biochemical results show that the small active-site conformational changes that occur upon OMP-peptide binding or deletion of the PDZ domain improve the nucleophilic character of the active-site serine.
How do the peptide-free PDZ domains keep DegS inactive? Our results suggest that R178 plays a key role. In the peptide-free DegS trimer, the R178 side chains in each subunit bind to the PDZ domains (Wilken et al., 2004; Zeth, 2004 ). The precise details of binding are probably not important, as slightly different contacts are observed in different crystal structures of unliganded DegS. In peptide-bound DegS or DegS
6PDZ
, the guanidinium group of R178 moves almost 20 Å away from its position in the peptide-free structure and makes a new set of hydrogenbonding interactions. Some of these hydrogen bonds are to main-chain atoms in the LD loop of an adjacent subunit. Others are to the side chain of Q191, which in turn contacts the T167 side chain in the adjacent LD loop; preliminary experiments suggest that T167A DegS is $30% active, whereas Q191A DegS is almost completely inactive. These R178-mediated contacts appear to stabilize an LD-loop conformation that then stabilizes the active conformation of the catalytic triad and oxyanion hole ( Figure 3F ). In support of this model, we find that the R178A mutant has low activity both in intact DegS and in DegS 6PDZ . Moreover, the LD-loop and active-site conformations are perturbed in our crystal structure of R178A DegS
. Thus, we propose that one of the principal ways in which the peptide-free PDZ domains inhibit DegS is by binding the R178 side chain.
How does OMP-peptide binding relieve inhibition by the DegS PDZ domains? If the tense and relaxed forms of DegS are in dynamic equilibrium, then OMP peptides would simply need to bind the relaxed structure tightly enough, compared to binding the tense structure, to tip the free-energy balance in favor of the relaxed state. Indeed, superposition of the peptide-bound and peptidefree PDZ domains reveals strong steric clashes between the peptide and parts of the peptide-free PDZ domain. Moreover, we find that OMP peptides bind about 10-fold more tightly to the isolated PDZ domain than to intact DegS. Thus, it appears that the relaxed conformation of the PDZ domain simply binds OMP peptides with higher affinity than the tense conformation. It will be interesting to see if peptides or mimics can be designed that bind preferentially to the tense PDZ conformation, as these should be potent inhibitors of the envelope-stress response in gram-negative bacteria, like E .coli, and might serve as antibiotics.
Numerous interactions between the unliganded PDZ domain and the protease domain of DegS contribute to stabilizing the tense state relative to the relaxed state ( Figure 3E ). For example, we found that nine different mutations in the PDZ domain, in the protease domain, or in the intradomain linker resulted in increased DegS activity in the absence of OMP peptides. In other PDZ proteases, interactions between the protease domain and inhibitory PDZ domains could easily be very different from those seen in DegS. Hence, it may be difficult to establish whether a PDZ domain in a protease plays an inhibitory role based only on sequence homology.
Positive cooperativity is a hallmark of multimeric allosteric enzymes, because binding of one ligand increases the equilibrium population of relaxed subunits and thus subsequent ligands bind with higher apparent affinity. As a consequence, binding curves are sigmoidal, and biological responses occur over narrower concentration ranges. We find that the binding of OMP peptides to DegS is positively cooperative, with a Hill constant near 2. Thus, DegS activity increases almost 10-fold with a 10-fold increase in OMP-peptide concentration and vice versa. In a noncooperative system, a 100-fold increase in OMP peptides would be required to achieve the same activity changes. We assume that there are always some unassembled OMPs in the periplasm and, thus, that DegS cleavage of RseA always occurs at a low level. Indeed, E. coli degS null mutants are nonviable because RseA inhibition of s E cannot be relieved (Alba et al., 2001) . As the concentration of unassembled or unfolded OMPs increased during envelope stress, however, DegS cleavage of RseA would also increase rapidly, ensuring a high-level s E transcriptional response. Similarly, as the levels of unassembled OMP fell because of degradation or assembly, the stress response would be turned off more rapidly. Thus, OMPs or OMP peptides function as allosteric effectors in the envelope-stress RIP cascade. It will be important to determine whether the same principles govern other RIP systems.
We also observe positive cooperativity in the binding of RseA substrates to DegS, which appears to arise from substrate-substrate interactions. Once the envelope-stress response is initiated, RseA levels decrease because of degradation but are also replenished because expression of the rseA gene levels is stimulated by s E (Alba and Gross, 2004) . Because DegS activity changes with the approximate square of the RseA concentration, the rate of cleavage by DegS would slow substantially as RseA levels in the membrane fell. At a systems level, this should result in reaching a new steady-state condition faster, because a lower synthesis rate would be needed to offset degradation.
Orthologs of DegS, DegP, DegQ, and HtrA2 are trimeric or hexameric, and thus it is likely that the entire family operates using similar allosteric principles. Indeed, HtrA2 and DegP are both activated by peptide binding, and deletion of the PDZ domain increases the activity of HtrA2 (Jones et al., 2002; Li et al., 2002; Martins et al., 2003; Gupta et al., 2004) . Moreover, the oxyanion hole is malformed in the crystal structures of E. coli DegP, human HtrA2, and Thermatoga maritima HtrA
, suggesting that these structures represent tense, catalytically inactive states Krojer et al., 2002; Li et al., 2002; Kim et al., 2003) . It will be interesting to see to what extent the regulatory strategies revealed for DegS also apply to its relatives.
EXPERIMENTAL PROCEDURES
Protein Expression, Purification, and Mutagenesis An N-terminally H 6 -tagged variant of E. coli DegS lacking the membrane anchor (residues 27-355), the same variant without the PDZ domain (DegS 6PDZ ; residues 27-256), and the periplasmic domain of E. coli RseA with a C-terminal H 6 tag (RseA peri ; residues 121-216)
were expressed and purified as described (Walsh et al., 2003; Cezairliyan and Sauer, 2007) . The fusion substrate, with an N-terminal H 6 tag and a C-terminal YQF sequence, was expressed and purified like RseA peri . Proteins were stored in a buffer containing 50 mM NaHPO 4 (pH 8.0), 200 mM NaCl, 10% glycerol, and 4 mM EDTA. Wild-type DegS, DegS DPDZ , and variants eluted as trimers in gel-filtration chromatography. For the expression of radioactive proteins, E. coli X90 DE3 cells were grown in a defined rich medium lacking methionine (TekNova). At OD 600 $0.5, IPTG (0.5 mM) to induce expression and 35 S-methionine (2 mCi; Perkin-Elmer) were added. Radioactive RseA peri was purified to > 95% homogeneity as described for the unlabeled protein. Mutations were generated by the QuikChange method (Stratagene) and confirmed by DNA sequencing. Mutant proteins were expressed and purified as described for the wild-type counterparts.
Peptides
All peptides were synthesized by the MIT Biopolymer Laboratory, purified by HPLC, and subjected to MALDI mass-spectrometry. One set of OMP peptides had free N and C-termini (DNRDGNVYAF, DNRDGNVYSF, DNRDGNVYDF, DNRDGNVYQF, DNRDGNVYRF, and DNRDGNVYYF); another set had an N-terminal fluorescein (fl-bA-KKDNRDGNYYF, fl-DNRDGNVYQF, and fl-bA-KKDNRDGNYAF).
Assays Degradation, binding, and modification experiments were performed in reaction buffer (150 mM NaHPO 4 [pH 8.3], 380 mM NaCl, 10% glycerol, and 4 mM EDTA) at 23 ± 1 C. Cleavage reactions were initiated by addition of enzyme or substrate to reaction buffer with or without OMP peptide. At each time point, 4 ml of the cleavage reaction was mixed with 25 ml of 10% TCA. After 20 min on ice, insoluble full-length substrate and the C-terminal cleavage product were separated from the soluble N-terminal product by centrifugation (16,000 3 g, 20 min, 4 C). TCA-soluble fractions were subjected to scintillation counting to determine the extent of cleavage. The presence of a H 6 tag at the N-or C terminus of substrates did not affect precipitation efficiency or DegS cleavage rates. Steady-state kinetic parameters were obtained by fitting data to the standard or Hill forms of the Michaelis-Menten equation using the non-linear-least-squares subroutine in the program KaleidaGraph.
For DFP experiments, DegS or DegS DPDZ (0.7-1.5 mM trimer) were pre-incubated with 10 mM DFP for 2, 5, and 10 min in the presence or absence of 40 mM YYF peptide. After these times, the reaction mixtures were diluted 25-fold into reaction buffer containing 35 mM YYF peptide and 150 mM 35 S-RseA peri , and the rate of substrate cleavage was determined. Pre-incubation of these enzymes with 0.4 mM DFP (the final concentration in the cleavage reaction) showed no inhibition under any conditions. Binding experiments monitored by fluorescence anisotropy (excitation 480 nm; emission 520 nm) were performed using a PTI QM-2000-4SE spectrofluorimeter (Photon Technology International, Birmingham, NJ). Fluorescein-labeled OMP peptides were diluted in reaction buffer to final concentrations of 60-100 nM, and increasing quantities of DegS or a variant were added. Data were collected for 90 s, averaged, corrected for protein scattering, and fitted with a quadratic form of a hyperbolic binding equation to determine K D .
Crystallography Hanging-drop vapor-diffusion crystallization was performed using DegS DPDZ or R178A DegS DPDZ at 20 mg/ml concentrations in 50 mM NaHPO 4 (pH 8.0), 200 mM NaCl, 5 mM EDTA, and 10% glycerol. Hampton Research Crystal Screens I and II and PEG-Ion screen were used for initial screening. The first DegS DPDZ crystal form (2QF0) was grown at 20 C by mixing the protein stock 1:1 with crystallization solution (50 mM sodium cacodylate, [pH 6], 150 mM sodium citrate, and 15% isopropanol). For cryoprotection, 1 ml of 50% MPD in well solution was added directly to $4 ml drops containing crystals; after 10 min, crystals were frozen in liquid nitrogen. DegS DPDZ 2QF3 crystals were obtained from Hampton Screen-II condition 27 (0.1 M Tris, [pH 8.5], 40% MPD, and 0.01 M ammonium phosphate monobasic) after two months and were frozen without cryoprotection. The R178A DegS DPDZ crystals were obtained in two weeks using 50 mM sodium cacodylate (pH 6), 100 mM sodium citrate, and 20% isopropanol at 20 C, and were frozen without cryoprotection.
A Rigaku MicroMax007-HF rotating anode source equipped with Varimax-HR mirrors, a RAXIS-IV detector, and an X-Stream cryo-system was used to screen frozen crystals and collect data for the 2QGR DegS DPDZ crystal. SAD data (l = 0.97918 Å ) from a Se-methionine crystal of DegS DPDZ (2QF0) were collected at the NE-CAT 24-ID-C beamline at the Argonne National Labs Advanced Photon Source. A total of 26 of 27 possible selenium sites were located using the HKL2MAP interface to SHELX (Pape and Schneider, 2004) . The validity of sites was confirmed by the interpretability of the density modified (DM) map produced by HKL2MAP. These sites were input into autoSHARP (Vonrhein et al., 2006) , which located the single missing site, and was used to refine sites, calculate experimental phases, and refine phases by density modification. The resulting DM map was used to build an initial model with COOT (Emsley & Cowtan, 2004) , which was refined using CNS (Brü nger et al., 1998) with iterative rebuilding in COOT. A trimeric search model was constructed from the refined model by removing loops with variable conformations from one of the three trimers in the asymmetric unit. This search model was used to obtain molecular-replacement phases for the 2QF3 crystal (data collected at the 24-ID-C beamline) using AMoRe (Navaza, 1994) and the 2QGR crystal using PHASER (Storoni et al., 2004) . Both structures were also built and refined with COOT and CNS.
